Research highlight

Next-generation personalized drug discovery: the tripeptide GHK hits center stage in chronic obstructive pulmonary disease

Silke Meiners and Oliver Eickelberg

Genome Medicine 2012, 4:70 (21 September 2012)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Meiners and Eickelberg highlight how a database-driven drug discovery study recently published in Genome Medicine paves the way to a better understanding and treatment of chronic lung diseases.

Subscription required

All research articles in Genome Medicine are open access. The journal also publishes a range of other articles that are available to subscribers.

Existing subscribers

Forgotten your password? help
Logon via Athens

Non subscribers